Healthcare Industry RSV Diagnostics Market Analysis Report, 2024 | Page 2

Hexa Research

Fact-based market research , penetrating industry insights and validated forecasts to help you make better decisions for a stronger future
Browse Details of Report @ https :// www . hexaresearch . com / research-report / respiratorysyncytial-virus-diagnostics-market
The global RSV Diagnostics market is categorized on the basis of products , end use , and regions . On the basis of products , the segments are DFA ( direct fluorescence antibody ) method , RADTs ( rapid antigen diagnostic tests ), flow cytometry , molecular diagnostics , gel microdroplets , diagnostic imaging , chromatographic immunoassay , and others . Due to high accuracy & precision , the molecular diagnostics segment may lead the overall industry during the forecast period .
Based on end uses , the industry is divided into clinics , hospitals , homecare , and laboratory . Hospitals held the largest share in 2015 . It is expected that this segment will continue dominating the RSV Diagnostics market because of high hospitalization rate of RSV infected patients . “ Homecare ” too may expand significantly in the forthcoming years because of high demand for perinatal & in-house testing . Surging popularity of homecare services owes to high governmental investments in training programs for the same .
Geographically , the global Respiratory Syncytial Virus Diagnostics Market is segmented into Latin America , Europe , North America , Asia Pacific , and the Middle East & Africa . With a market share surpassing 45 %, North America led the industry in 2015 . This region is propelled by high incidence of respiratory tract infections . Governmental initiatives , such as PAHO ( Pan American Health Organization ) may significantly contribute to market demand over the next couple of years . As per this initiative , it is absolutely necessary to rule out the possibilities of infections & metabolic defects in newborns .
Asia Pacific may register a high growth rate from 2016 to 2024 . High incidence of infectious diseases fueled by moderate to poor living conditions propels this regional market . Other factors that may drive this region are improved healthcare infrastructure , high R & D funding , favorable government mandates , and steady technological advancements .
Contact : + 1-800-489-3075
Email : sales @ hexaresearch . com Website : http :// www . hexaresearch . com /